QUICK ANSWER

TL;DR

THCA, delta-8, THCP, HHC, and other hemp-derived cannabinoid merchants face unusually fast-changing legal and payment risk. Underwriting should be based on the exact compounds, product forms, lab results, source materials, claims, age controls, destinations, and current federal/state rules—not a generic statement that every product is “Farm Bill compliant.”

OFFICIAL RULES AND APPROVAL PRACTICE

Know which is which

Government and card-network materials establish official requirements. Provider risk appetite and underwriting criteria are commercial decisions that can vary. ORCA helps merchants understand the difference, prepare the right evidence, and pursue an approval path that supports compliant processing.

AT A GLANCE

What does this guide answer?

  • Do not reduce the analysis to one THC number?
  • What underwriters may request?
  • What should merchants know about keep the catalog synchronized?
  • What should merchants know about use current regulatory sources?
01

QUESTION

Do not reduce the analysis to one THC number?

ANSWER

Cannabinoid review should consider source material, production method, total and individual cannabinoid content, product form, claims, state restrictions, and changing federal definitions.

  • Do not reduce the analysis to a single delta-9 result or assume the word “hemp” resolves every issue.
What to do
  • For do not reduce the analysis to one thc number, keep the evidence simple and reviewable: identify the responsible owner, preserve the supporting documents, write down the provider’s requirement, and confirm the result in the account’s reports or agreement.
  • CBD and hemp merchants are easier to place when product composition, claims, testing, sourcing, labeling, and destination controls are organized before the application reaches underwriting.
  • These steps make the application easier to understand and give ORCA more to work with when matching the business to an appropriate processing relationship.
02

QUESTION

What underwriters may request?

ANSWER

This part of THCA, Delta-8 & Hemp-Derived Cannabinoid Payment Underwriting should be evaluated against the merchant’s actual agreement and operating model.

  • CBD and hemp merchants are easier to place when product composition, claims, testing, sourcing, labeling, and destination controls are organized before the application reaches underwriting.
What to do
  • For what underwriters may request, keep the evidence simple and reviewable: identify the responsible owner, preserve the supporting documents, write down the provider’s requirement, and confirm the result in the account’s reports or agreement.
  • CBD and hemp merchants are easier to place when product composition, claims, testing, sourcing, labeling, and destination controls are organized before the application reaches underwriting.
  • These steps make the application easier to understand and give ORCA more to work with when matching the business to an appropriate processing relationship.
03

QUESTION

What should merchants know about keep the catalog synchronized?

ANSWER

The complete product mix matters because one unsupported item can change the program required for the entire account.

  • Provide current product pages, ingredient or inventory lists, pricing, supplier information, and a plain description of what customers receive.
  • Do not rely on broad labels that hide regulated or restricted items.
What to do
  • For keep the catalog synchronized, keep the evidence simple and reviewable: identify the responsible owner, preserve the supporting documents, write down the provider’s requirement, and confirm the result in the account’s reports or agreement.
  • CBD and hemp merchants are easier to place when product composition, claims, testing, sourcing, labeling, and destination controls are organized before the application reaches underwriting.
  • These steps make the application easier to understand and give ORCA more to work with when matching the business to an appropriate processing relationship.
04

QUESTION

What should merchants know about use current regulatory sources?

ANSWER

Cannabinoid review should consider source material, production method, total and individual cannabinoid content, product form, claims, state restrictions, and changing federal definitions.

  • Do not reduce the analysis to a single delta-9 result or assume the word “hemp” resolves every issue.
What to do
  • For use current regulatory sources, keep the evidence simple and reviewable: identify the responsible owner, preserve the supporting documents, write down the provider’s requirement, and confirm the result in the account’s reports or agreement.
  • CBD and hemp merchants are easier to place when product composition, claims, testing, sourcing, labeling, and destination controls are organized before the application reaches underwriting.
  • These steps make the application easier to understand and give ORCA more to work with when matching the business to an appropriate processing relationship.

FREQUENTLY ASKED

Questions, answered

Does “hemp-derived” automatically mean a product can be processed?

CBD and hemp merchants are easier to place when product composition, claims, testing, sourcing, labeling, and destination controls are organized before the application reaches underwriting. The exact answer depends on the written program terms and the merchant’s facts, so confirm it with the responsible provider before relying on it operationally.

Should I send COAs during underwriting?

CBD and hemp merchants are easier to place when product composition, claims, testing, sourcing, labeling, and destination controls are organized before the application reaches underwriting. The exact answer depends on the written program terms and the merchant’s facts, so confirm it with the responsible provider before relying on it operationally.

Why are these accounts often reviewed more closely?

CBD and hemp merchants are easier to place when product composition, claims, testing, sourcing, labeling, and destination controls are organized before the application reaches underwriting. The exact answer depends on the written program terms and the merchant’s facts, so confirm it with the responsible provider before relying on it operationally.

PRIMARY SOURCES

Reference material

  1. FDA , Warning letters for cannabis-derived products
  2. USDA , Hemp production program

YOUR NEXT STEP

Need a path specific to your business?

Learn how ORCA approaches payment processing for complex merchant profiles.

Explore your options